Table 2 Association between liver fibrosis severity based on the fibrosis-4 index score and baseline CAC score.

From: Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease

 

Non-NAFLD

NAFLD

Low

Intermediate/high

Crude OR

1.00 (Ref)

1.28 (0.98–1.66)

2.27 (1.60–3.20)

Model 1

1.00 (Ref)

0.91 (0.68–1.20)

1.56 (1.08–2.25)

Model 2

1.00 (Ref)

0.82 (0.61–1.11)

1.41 (0.96–2.07)

Model 3

1.00 (Ref)

0.83 (0.61–1.13)

1.39 (0.94–2.05)

  1. OR for CAC score > 0 in reference to a CAC score = 0.
  2. Model 1 was adjusted for sex and body mass index.
  3. Model 2 was adjusted for the variables included in model 1 plus smoking, drinking, and exercise habits; and the presence of hypertension and type 2 diabetes mellitus.
  4. Model 3 was adjusted for the variables included in model 2 plus triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein concentrations.
  5. CAC, coronary artery calcification; NAFLD, nonalcoholic fatty liver disease; OR, odds ratio.
Back to article page